Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/214067
Title: | Prognostic Value of D-dimer to Lymphocyte Ratio (DLR) in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients: A Validation Study in a National Cohort |
Author: | Oblitas, Crhistian-mario Demelo-rodríguez, Pablo Alvarez-sala-walther, Luis-antonio Rubio-rivas, Manuel Navarro-romero, Francisco Giner Galvañ, Vicente De Jorge-huerta, Lucía Fonseca Aizpuru, Eva García García, Gema María Beato Pérez, José Luis Pesqueira Fontan, Paula María Artero Mora, Arturo Vargas Núñez, Juan Antonio Ramírez Perea, Nuria García Bruñén, José Miguel Roy Vallejo, Emilia Perales-fraile, Isabel Gil Sánchez, Ricardo López Castro, José Martínez González, Ángel Luis Díez García, Luis Felipe Aroza Espinar, Marina Casas-rojo, José-manuel Millán Núñez-cortés, Jesús |
Issue Date: | 22-Feb-2024 |
Publisher: | MDPI AG |
Abstract: | Background: This study aimed to validate the role of the D-dimer to lymphocyte ratio (DLR) for mortality prediction in a large national cohort of hospitalized coronavirus disease 2019 (COVID-19) patients. Methods: A retrospective, multicenter, observational study that included hospitalized patients due to SARS-CoV-2 infection in Spain was conducted from March 2020 to March 2022. All biomarkers and laboratory indices analyzed were measured once at admission. Results: A total of 10,575 COVID-19 patients were included in this study. The mean age of participants was 66.9 (+/- 16) years, and 58.6% (6202 patients) of them were male. The overall mortality rate was 16.3% (n = 1726 patients). Intensive care unit admission was needed in 10.5% (n = 1106 patients), non-invasive mechanical ventilation was required in 8.8% (n = 923 patients), and orotracheal intubation was required in 7.5% (789 patients). DLR presented a c-statistic of 0.69 (95% CI, 0.68-0.71) for in-hospital mortality with an optimal cut-off above 1. Multivariate analysis showed an independent association for in-hospital mortality for DLR > 1 (adjusted OR 2.09, 95% CI 1.09-4.04; p = 0.03); in the same way, survival analysis showed a higher mortality risk for DLR > 1 (HR 2.24; 95% CI 2.03-2.47; p < 0.01). Further, no other laboratory indices showed an independent association for mortality in multivariate analysis. Conclusions: This study confirmed the usefulness of DLR as a prognostic biomarker for mortality associated with SARS-CoV-2 infection, being an accessible, cost-effective, and easy-to-use biomarker in daily clinical practice. |
Note: | Reproducció del document publicat a: https://doi.org/10.3390/v16030335 |
It is part of: | Viruses, 2024, vol. 16, issue. 3, p. 335 |
URI: | http://hdl.handle.net/2445/214067 |
Related resource: | https://doi.org/10.3390/v16030335 |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
viruses-16-00335-v2.pdf | 844.38 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.